Can bupropion (Wellbutrin) cause acute pancreatitis?

Bupropion (Wellbutrin) and Acute Pancreatitis

Bupropion is NOT listed as a known cause of acute pancreatitis in the FDA drug label, and there is no credible published evidence linking it to pancreatitis. The official FDA prescribing information for Wellbutrin does not include pancreatitis among its adverse effects, overdose complications, or warnings 1.

Evidence Assessment

When evaluating drug-induced pancreatitis, the strength of evidence matters critically. The most rigorous classification systems require either:

• Class I evidence: Documented recurrence upon rechallenge with the drug 2
• Class II evidence: Consistent latency period in ≥75% of reported cases 2
• Definite causality: Symptoms recur upon rechallenge, as defined by WHO criteria 3

Bupropion does not appear in any published classification of drugs associated with pancreatitis. The comprehensive reviews of drug-induced pancreatitis from 2005-2012 catalogued hundreds of implicated medications—including azathioprine, atorvastatin, enalapril, valproic acid, and many others—but bupropion is conspicuously absent from all evidence classes 2, 4, 3, 5.

Clinical Implications

When a patient on bupropion presents with abdominal pain and elevated pancreatic enzymes:

• Do NOT attribute pancreatitis to bupropion without exhaustively excluding other causes
• Prioritize the common etiologies: gallstones (40%), alcohol (30%), hypertriglyceridemia, hypercalcemia, trauma, and anatomic abnormalities 6
• Review ALL other medications the patient takes—particularly statins (atorvastatin), ACE inhibitors (enalapril), immunosuppressants (azathioprine), and diuretics (furosemide, hydrochlorothiazide), which have established associations 7, 5
• Obtain lipase (preferred over amylase for diagnosis) and contrast-enhanced CT if diagnosis is uncertain 6

The Misidentification Trap

A recent 2026 review warns about the "misidentification trap" where drug-induced adverse effects are mistakenly attributed to other causes 8. However, this works both ways: clinicians must avoid falsely blaming medications that lack evidence, as this can lead to unnecessary discontinuation of effective psychiatric treatment.

For bupropion specifically:

• The FDA overdose section lists seizures (in one-third of cases), hallucinations, cardiac arrhythmias, rhabdomyolysis, and respiratory failure—but NOT pancreatitis 1
• If pancreatitis occurs in a patient taking bupropion, the median latency for true drug-induced pancreatitis is 160.5 days 7, but you should still assume another etiology unless proven otherwise

Diagnostic Algorithm

1. Confirm pancreatitis: Lipase >3× upper limit of normal + characteristic abdominal pain + imaging findings 6
2. Exclude common causes: Ultrasound for gallstones, alcohol history, triglyceride and calcium levels
3. Review medication list: Focus on Class I and II drugs with established evidence 2, 5
4. If truly idiopathic: Consider rare causes (autoimmune, genetic, anatomic) before attributing to bupropion
5. Do NOT discontinue bupropion unless all other causes are definitively excluded and temporal relationship is compelling

The goal should be to determine etiology in ≥80% of cases, with <20% classified as idiopathic 6. Bupropion should not be used as a convenient explanation when the true cause remains unidentified.